| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Attention Deficit Disorder with Hyperactivity | 208 | 2024 | 282 | 41.490 |
Why?
|
| Central Nervous System Stimulants | 65 | 2023 | 174 | 14.740 |
Why?
|
| Methylphenidate | 49 | 2023 | 55 | 11.300 |
Why?
|
| Behavior Therapy | 55 | 2022 | 167 | 11.270 |
Why?
|
| Child | 208 | 2024 | 3131 | 8.040 |
Why?
|
| Parents | 43 | 2024 | 329 | 7.010 |
Why?
|
| Parenting | 28 | 2024 | 127 | 5.430 |
Why?
|
| Parent-Child Relations | 19 | 2024 | 110 | 4.800 |
Why?
|
| Adolescent | 119 | 2024 | 5363 | 4.780 |
Why?
|
| Substance-Related Disorders | 18 | 2024 | 730 | 4.100 |
Why?
|
| Humans | 256 | 2024 | 37093 | 3.500 |
Why?
|
| Male | 194 | 2024 | 20025 | 3.410 |
Why?
|
| Female | 173 | 2024 | 20969 | 3.000 |
Why?
|
| Child, Preschool | 57 | 2021 | 1418 | 2.670 |
Why?
|
| Child Behavior Disorders | 12 | 2020 | 35 | 2.600 |
Why?
|
| Treatment Outcome | 50 | 2022 | 1369 | 2.450 |
Why?
|
| Conduct Disorder | 23 | 2020 | 49 | 2.420 |
Why?
|
| Schools | 19 | 2024 | 260 | 2.310 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 23 | 2019 | 53 | 2.260 |
Why?
|
| Adolescent Behavior | 9 | 2024 | 253 | 2.230 |
Why?
|
| Child Behavior | 17 | 2021 | 78 | 2.200 |
Why?
|
| Mothers | 10 | 2022 | 181 | 2.120 |
Why?
|
| Longitudinal Studies | 39 | 2023 | 885 | 2.070 |
Why?
|
| Peer Group | 15 | 2020 | 156 | 2.030 |
Why?
|
| Psychiatric Status Rating Scales | 19 | 2022 | 253 | 1.990 |
Why?
|
| Depression | 12 | 2023 | 712 | 1.900 |
Why?
|
| Social Behavior | 19 | 2020 | 131 | 1.830 |
Why?
|
| Executive Function | 4 | 2022 | 49 | 1.700 |
Why?
|
| Child of Impaired Parents | 7 | 2020 | 18 | 1.650 |
Why?
|
| Juvenile Delinquency | 7 | 2020 | 44 | 1.650 |
Why?
|
| Memory, Short-Term | 8 | 2021 | 49 | 1.630 |
Why?
|
| Automobile Driving | 4 | 2016 | 24 | 1.590 |
Why?
|
| Psychotherapy, Group | 4 | 2015 | 22 | 1.580 |
Why?
|
| Adult | 66 | 2023 | 11712 | 1.530 |
Why?
|
| Mass Screening | 5 | 2024 | 462 | 1.510 |
Why?
|
| Combined Modality Therapy | 28 | 2020 | 148 | 1.500 |
Why?
|
| Self Concept | 10 | 2022 | 154 | 1.490 |
Why?
|
| Alcohol Drinking | 12 | 2022 | 519 | 1.490 |
Why?
|
| Students | 5 | 2024 | 519 | 1.460 |
Why?
|
| Cognition | 11 | 2021 | 398 | 1.390 |
Why?
|
| Interpersonal Relations | 11 | 2017 | 205 | 1.380 |
Why?
|
| Alcoholism | 9 | 2020 | 240 | 1.290 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 16 | 2016 | 98 | 1.270 |
Why?
|
| Caregivers | 7 | 2022 | 182 | 1.250 |
Why?
|
| Cost of Illness | 3 | 2019 | 76 | 1.240 |
Why?
|
| Family Therapy | 3 | 2016 | 21 | 1.130 |
Why?
|
| Family | 6 | 2019 | 173 | 1.100 |
Why?
|
| Double-Blind Method | 20 | 2022 | 286 | 1.080 |
Why?
|
| Mood Disorders | 3 | 2016 | 48 | 1.060 |
Why?
|
| Mental Disorders | 4 | 2022 | 309 | 1.040 |
Why?
|
| Achievement | 7 | 2022 | 24 | 1.040 |
Why?
|
| Young Adult | 27 | 2022 | 4268 | 1.010 |
Why?
|
| Child Development | 8 | 2017 | 88 | 0.960 |
Why?
|
| Prospective Studies | 11 | 2023 | 1378 | 0.920 |
Why?
|
| Body Height | 2 | 2021 | 53 | 0.920 |
Why?
|
| Depressive Disorder | 4 | 2020 | 174 | 0.920 |
Why?
|
| Employment | 3 | 2019 | 76 | 0.890 |
Why?
|
| Impulsive Behavior | 4 | 2021 | 46 | 0.890 |
Why?
|
| Cohort Studies | 11 | 2023 | 1492 | 0.840 |
Why?
|
| Empathy | 4 | 2020 | 28 | 0.830 |
Why?
|
| Body Weight | 2 | 2021 | 434 | 0.830 |
Why?
|
| Severity of Illness Index | 15 | 2019 | 610 | 0.820 |
Why?
|
| Linear Models | 2 | 2022 | 275 | 0.820 |
Why?
|
| Pennsylvania | 13 | 2021 | 42 | 0.810 |
Why?
|
| Friends | 3 | 2017 | 22 | 0.810 |
Why?
|
| Models, Psychological | 8 | 2021 | 131 | 0.780 |
Why?
|
| Marijuana Abuse | 2 | 2022 | 91 | 0.770 |
Why?
|
| Time Perception | 1 | 2021 | 7 | 0.770 |
Why?
|
| Psychomotor Performance | 4 | 2019 | 136 | 0.770 |
Why?
|
| Education, Distance | 1 | 2021 | 44 | 0.760 |
Why?
|
| Family Relations | 3 | 2017 | 46 | 0.760 |
Why?
|
| Antisocial Personality Disorder | 5 | 2016 | 17 | 0.760 |
Why?
|
| Attention | 10 | 2022 | 156 | 0.750 |
Why?
|
| Comorbidity | 19 | 2020 | 623 | 0.740 |
Why?
|
| Reward | 3 | 2020 | 79 | 0.730 |
Why?
|
| Father-Child Relations | 6 | 2019 | 12 | 0.730 |
Why?
|
| Cognition Disorders | 4 | 2020 | 233 | 0.720 |
Why?
|
| Body Mass Index | 2 | 2021 | 854 | 0.720 |
Why?
|
| Stress, Psychological | 6 | 2019 | 583 | 0.670 |
Why?
|
| Sports | 2 | 2017 | 48 | 0.660 |
Why?
|
| Income | 1 | 2019 | 140 | 0.650 |
Why?
|
| Parasympathetic Nervous System | 1 | 2018 | 8 | 0.650 |
Why?
|
| Adolescent Development | 3 | 2022 | 31 | 0.650 |
Why?
|
| Educational Status | 9 | 2016 | 313 | 0.640 |
Why?
|
| Quality of Life | 2 | 2022 | 481 | 0.630 |
Why?
|
| Emotions | 5 | 2022 | 220 | 0.630 |
Why?
|
| Follow-Up Studies | 26 | 2020 | 974 | 0.630 |
Why?
|
| Mother-Child Relations | 9 | 2012 | 59 | 0.610 |
Why?
|
| Anxiety | 4 | 2022 | 754 | 0.590 |
Why?
|
| Patient Preference | 2 | 2015 | 44 | 0.590 |
Why?
|
| Aggression | 7 | 2011 | 89 | 0.580 |
Why?
|
| Dose-Response Relationship, Drug | 13 | 2018 | 1039 | 0.570 |
Why?
|
| Cross-Over Studies | 6 | 2022 | 108 | 0.570 |
Why?
|
| Financing, Personal | 1 | 2016 | 9 | 0.570 |
Why?
|
| Human Development | 1 | 2016 | 8 | 0.550 |
Why?
|
| Risk-Taking | 4 | 2015 | 451 | 0.550 |
Why?
|
| School Health Services | 3 | 2005 | 81 | 0.550 |
Why?
|
| Independent Living | 1 | 2016 | 30 | 0.540 |
Why?
|
| Models, Theoretical | 1 | 2017 | 217 | 0.540 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2016 | 268 | 0.540 |
Why?
|
| Evidence-Based Practice | 2 | 2020 | 45 | 0.530 |
Why?
|
| Risk Factors | 16 | 2022 | 3562 | 0.530 |
Why?
|
| Dextroamphetamine | 2 | 2014 | 10 | 0.520 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 144 | 0.520 |
Why?
|
| Social Adjustment | 6 | 2011 | 30 | 0.520 |
Why?
|
| Fathers | 5 | 2019 | 33 | 0.510 |
Why?
|
| Social Perception | 4 | 2016 | 62 | 0.500 |
Why?
|
| Neuropsychological Tests | 8 | 2021 | 259 | 0.500 |
Why?
|
| Drug Administration Schedule | 7 | 2016 | 143 | 0.500 |
Why?
|
| Propylamines | 2 | 2011 | 6 | 0.480 |
Why?
|
| Delayed-Action Preparations | 3 | 2021 | 60 | 0.470 |
Why?
|
| Evidence-Based Medicine | 2 | 2005 | 97 | 0.460 |
Why?
|
| Illusions | 3 | 2008 | 4 | 0.450 |
Why?
|
| Personality | 3 | 2020 | 42 | 0.450 |
Why?
|
| Social Environment | 6 | 2011 | 207 | 0.450 |
Why?
|
| Education, Special | 3 | 2024 | 11 | 0.440 |
Why?
|
| Video Recording | 2 | 2011 | 32 | 0.430 |
Why?
|
| Punishment | 2 | 2024 | 6 | 0.420 |
Why?
|
| Family Conflict | 3 | 2012 | 11 | 0.410 |
Why?
|
| Analysis of Variance | 7 | 2016 | 550 | 0.410 |
Why?
|
| Music | 2 | 2011 | 25 | 0.410 |
Why?
|
| Reproducibility of Results | 13 | 2022 | 935 | 0.410 |
Why?
|
| Personality Assessment | 13 | 2008 | 42 | 0.390 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2011 | 4 | 0.390 |
Why?
|
| Internal-External Control | 7 | 2008 | 53 | 0.380 |
Why?
|
| Case-Control Studies | 9 | 2019 | 1130 | 0.380 |
Why?
|
| Patient Education as Topic | 2 | 2012 | 215 | 0.380 |
Why?
|
| Program Development | 4 | 2009 | 233 | 0.380 |
Why?
|
| Pilot Projects | 7 | 2019 | 661 | 0.370 |
Why?
|
| United States | 10 | 2024 | 4223 | 0.360 |
Why?
|
| Health Care Costs | 3 | 2007 | 77 | 0.360 |
Why?
|
| Memory Disorders | 3 | 2021 | 73 | 0.360 |
Why?
|
| Pediatrics | 2 | 2020 | 68 | 0.340 |
Why?
|
| Factor Analysis, Statistical | 2 | 2021 | 146 | 0.330 |
Why?
|
| Deception | 2 | 2019 | 6 | 0.320 |
Why?
|
| Mental Health Services | 2 | 2015 | 118 | 0.320 |
Why?
|
| Prognosis | 6 | 2019 | 739 | 0.320 |
Why?
|
| Alcohol-Related Disorders | 2 | 2021 | 55 | 0.320 |
Why?
|
| Medication Adherence | 3 | 2016 | 179 | 0.310 |
Why?
|
| Loneliness | 2 | 2007 | 11 | 0.310 |
Why?
|
| Adaptation, Psychological | 7 | 2022 | 385 | 0.300 |
Why?
|
| Middle Ear Ventilation | 1 | 2007 | 1 | 0.290 |
Why?
|
| Otitis Media with Effusion | 1 | 2007 | 1 | 0.290 |
Why?
|
| Logistic Models | 2 | 2020 | 923 | 0.280 |
Why?
|
| Mental Health | 4 | 2022 | 303 | 0.280 |
Why?
|
| Single Parent | 3 | 2012 | 4 | 0.270 |
Why?
|
| Research Design | 3 | 2017 | 313 | 0.270 |
Why?
|
| Teaching | 3 | 2008 | 55 | 0.270 |
Why?
|
| Child Rearing | 2 | 2019 | 10 | 0.260 |
Why?
|
| Socialization | 3 | 2019 | 19 | 0.260 |
Why?
|
| Prevalence | 8 | 2023 | 1455 | 0.260 |
Why?
|
| Interview, Psychological | 4 | 2016 | 61 | 0.260 |
Why?
|
| Tobacco Use Disorder | 2 | 2021 | 237 | 0.260 |
Why?
|
| Monte Carlo Method | 2 | 2022 | 57 | 0.260 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 3 | 2011 | 50 | 0.250 |
Why?
|
| Videoconferencing | 1 | 2024 | 5 | 0.240 |
Why?
|
| Task Performance and Analysis | 3 | 2022 | 37 | 0.240 |
Why?
|
| Assertiveness | 3 | 2009 | 7 | 0.240 |
Why?
|
| Telephone | 1 | 2024 | 34 | 0.240 |
Why?
|
| Depressive Disorder, Major | 4 | 2010 | 103 | 0.240 |
Why?
|
| Sensitivity and Specificity | 3 | 2022 | 562 | 0.230 |
Why?
|
| Marijuana Smoking | 2 | 2015 | 85 | 0.230 |
Why?
|
| Statistics as Topic | 3 | 2015 | 117 | 0.230 |
Why?
|
| Infant | 3 | 2022 | 1046 | 0.220 |
Why?
|
| Attitude | 2 | 2021 | 104 | 0.220 |
Why?
|
| Opiate Alkaloids | 1 | 2023 | 8 | 0.220 |
Why?
|
| Models, Statistical | 1 | 2024 | 180 | 0.220 |
Why?
|
| Administration, Cutaneous | 3 | 2010 | 43 | 0.220 |
Why?
|
| Nicotine | 2 | 2023 | 257 | 0.220 |
Why?
|
| Smoking | 4 | 2016 | 940 | 0.210 |
Why?
|
| Referral and Consultation | 3 | 2016 | 117 | 0.210 |
Why?
|
| Programming Languages | 1 | 2022 | 28 | 0.210 |
Why?
|
| Regression Analysis | 7 | 2013 | 455 | 0.210 |
Why?
|
| Risk | 5 | 2016 | 267 | 0.210 |
Why?
|
| Algorithms | 4 | 2020 | 465 | 0.210 |
Why?
|
| Reference Values | 1 | 2022 | 212 | 0.210 |
Why?
|
| Retrospective Studies | 3 | 2019 | 2026 | 0.210 |
Why?
|
| Appetite | 1 | 2021 | 21 | 0.200 |
Why?
|
| Psychometrics | 9 | 2021 | 318 | 0.200 |
Why?
|
| Classification | 1 | 2021 | 7 | 0.200 |
Why?
|
| Politics | 1 | 2021 | 40 | 0.200 |
Why?
|
| Cannabis | 1 | 2023 | 79 | 0.190 |
Why?
|
| Child Abuse | 1 | 2022 | 79 | 0.190 |
Why?
|
| Disease Progression | 3 | 2019 | 601 | 0.190 |
Why?
|
| Actigraphy | 1 | 2020 | 15 | 0.190 |
Why?
|
| Education | 4 | 2009 | 55 | 0.190 |
Why?
|
| Age Factors | 7 | 2018 | 1033 | 0.190 |
Why?
|
| House Calls | 1 | 2020 | 9 | 0.180 |
Why?
|
| Middle Aged | 6 | 2019 | 10129 | 0.180 |
Why?
|
| Survival Analysis | 2 | 2019 | 325 | 0.180 |
Why?
|
| Curriculum | 1 | 2022 | 265 | 0.180 |
Why?
|
| Insurance Claim Review | 1 | 2019 | 28 | 0.170 |
Why?
|
| Managed Care Programs | 1 | 2019 | 38 | 0.170 |
Why?
|
| Morals | 1 | 2019 | 13 | 0.170 |
Why?
|
| Observer Variation | 5 | 2021 | 52 | 0.170 |
Why?
|
| Violence | 1 | 2020 | 134 | 0.160 |
Why?
|
| Life Change Events | 2 | 2017 | 92 | 0.160 |
Why?
|
| Infant, Newborn | 1 | 2021 | 894 | 0.160 |
Why?
|
| Anger | 2 | 2016 | 21 | 0.160 |
Why?
|
| Patient Dropouts | 2 | 2012 | 29 | 0.160 |
Why?
|
| Adrenergic alpha-Agonists | 2 | 2008 | 34 | 0.160 |
Why?
|
| Affect | 3 | 2016 | 152 | 0.160 |
Why?
|
| Sex Factors | 4 | 2023 | 898 | 0.150 |
Why?
|
| Computer Simulation | 2 | 2021 | 362 | 0.150 |
Why?
|
| Law Enforcement | 1 | 2017 | 14 | 0.150 |
Why?
|
| Clonidine | 2 | 2008 | 52 | 0.150 |
Why?
|
| Negotiating | 1 | 2017 | 25 | 0.150 |
Why?
|
| Seasons | 1 | 2018 | 112 | 0.150 |
Why?
|
| Social Support | 2 | 2012 | 394 | 0.150 |
Why?
|
| Irritable Mood | 1 | 2016 | 2 | 0.150 |
Why?
|
| Communication Disorders | 1 | 2016 | 4 | 0.140 |
Why?
|
| Language Tests | 1 | 2016 | 22 | 0.140 |
Why?
|
| Motivation | 2 | 2012 | 436 | 0.140 |
Why?
|
| Psychological Tests | 2 | 2007 | 53 | 0.140 |
Why?
|
| Communication | 3 | 2022 | 180 | 0.140 |
Why?
|
| Fear | 1 | 2019 | 249 | 0.140 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 494 | 0.140 |
Why?
|
| Foster Home Care | 1 | 2016 | 11 | 0.140 |
Why?
|
| Psychology | 2 | 2007 | 36 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 145 | 0.130 |
Why?
|
| Spouse Abuse | 2 | 2014 | 43 | 0.130 |
Why?
|
| Reaction Time | 4 | 2009 | 143 | 0.130 |
Why?
|
| Polymorphism, Genetic | 3 | 2011 | 191 | 0.120 |
Why?
|
| Medical Records | 1 | 2014 | 41 | 0.120 |
Why?
|
| Socioeconomic Factors | 7 | 2022 | 1067 | 0.120 |
Why?
|
| Mental Recall | 1 | 2014 | 78 | 0.120 |
Why?
|
| Sociometric Techniques | 3 | 2007 | 4 | 0.110 |
Why?
|
| Psychopathology | 1 | 2012 | 15 | 0.110 |
Why?
|
| Self Disclosure | 2 | 2010 | 42 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 583 | 0.110 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 47 | 0.100 |
Why?
|
| Individuality | 1 | 2011 | 46 | 0.100 |
Why?
|
| Predictive Value of Tests | 6 | 2007 | 400 | 0.100 |
Why?
|
| Maternal Behavior | 1 | 2011 | 22 | 0.100 |
Why?
|
| Dysthymic Disorder | 1 | 2010 | 3 | 0.100 |
Why?
|
| Aged | 1 | 2022 | 6741 | 0.090 |
Why?
|
| Baseball | 1 | 1990 | 2 | 0.090 |
Why?
|
| Time Factors | 6 | 2014 | 1742 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 4 | 2012 | 111 | 0.090 |
Why?
|
| Program Evaluation | 2 | 2008 | 339 | 0.090 |
Why?
|
| Suicide, Attempted | 1 | 2010 | 91 | 0.080 |
Why?
|
| Divorce | 1 | 2008 | 5 | 0.080 |
Why?
|
| Forecasting | 2 | 2013 | 128 | 0.080 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2009 | 73 | 0.080 |
Why?
|
| Personal Construct Theory | 1 | 2008 | 1 | 0.080 |
Why?
|
| Socioenvironmental Therapy | 1 | 2008 | 1 | 0.080 |
Why?
|
| Token Economy | 1 | 2008 | 1 | 0.080 |
Why?
|
| Saliva | 1 | 2009 | 107 | 0.080 |
Why?
|
| Space Perception | 1 | 2008 | 33 | 0.080 |
Why?
|
| ROC Curve | 1 | 2008 | 138 | 0.080 |
Why?
|
| Visual Perception | 1 | 2008 | 67 | 0.080 |
Why?
|
| Cues | 1 | 2008 | 55 | 0.080 |
Why?
|
| Models, Econometric | 1 | 2007 | 5 | 0.080 |
Why?
|
| Eating | 1 | 2009 | 166 | 0.080 |
Why?
|
| Social Problems | 1 | 2007 | 14 | 0.070 |
Why?
|
| Hierarchy, Social | 1 | 2007 | 9 | 0.070 |
Why?
|
| Aptitude | 1 | 2006 | 5 | 0.070 |
Why?
|
| Defense Mechanisms | 1 | 2006 | 9 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2008 | 156 | 0.070 |
Why?
|
| Object Attachment | 1 | 2007 | 24 | 0.070 |
Why?
|
| Culture | 1 | 2008 | 173 | 0.070 |
Why?
|
| Patient Compliance | 2 | 2010 | 212 | 0.070 |
Why?
|
| Hyperkinesis | 1 | 2006 | 7 | 0.070 |
Why?
|
| International Classification of Diseases | 1 | 2006 | 19 | 0.070 |
Why?
|
| Public Sector | 1 | 2005 | 19 | 0.070 |
Why?
|
| Problem Solving | 3 | 2009 | 35 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 864 | 0.070 |
Why?
|
| Health Education | 1 | 2009 | 338 | 0.070 |
Why?
|
| Early Diagnosis | 2 | 2019 | 64 | 0.060 |
Why?
|
| Minisatellite Repeats | 3 | 2011 | 18 | 0.060 |
Why?
|
| Behavior | 1 | 2005 | 32 | 0.060 |
Why?
|
| Personal Satisfaction | 1 | 2005 | 64 | 0.060 |
Why?
|
| Drug Utilization | 1 | 2004 | 29 | 0.060 |
Why?
|
| Heart Rate | 3 | 2008 | 253 | 0.060 |
Why?
|
| Costs and Cost Analysis | 2 | 2020 | 57 | 0.060 |
Why?
|
| Interviews as Topic | 2 | 2020 | 381 | 0.060 |
Why?
|
| Mental Competency | 1 | 2004 | 11 | 0.060 |
Why?
|
| Faculty | 3 | 2011 | 94 | 0.060 |
Why?
|
| Age of Onset | 2 | 2016 | 100 | 0.060 |
Why?
|
| Data Collection | 1 | 2004 | 194 | 0.060 |
Why?
|
| Pitch Discrimination | 1 | 2002 | 2 | 0.060 |
Why?
|
| Substance Abuse Detection | 1 | 2023 | 30 | 0.050 |
Why?
|
| Choice Behavior | 3 | 2009 | 79 | 0.050 |
Why?
|
| Bipolar Disorder | 1 | 2003 | 43 | 0.050 |
Why?
|
| Emergency Services, Psychiatric | 1 | 2002 | 8 | 0.050 |
Why?
|
| Genotype | 3 | 2011 | 730 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2002 | 41 | 0.050 |
Why?
|
| Vulnerable Populations | 1 | 2003 | 140 | 0.050 |
Why?
|
| Affective Symptoms | 1 | 2002 | 57 | 0.050 |
Why?
|
| North Carolina | 1 | 2022 | 104 | 0.050 |
Why?
|
| Guidelines as Topic | 1 | 2002 | 54 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2023 | 142 | 0.050 |
Why?
|
| Police | 1 | 2021 | 17 | 0.050 |
Why?
|
| Blinking | 3 | 2010 | 10 | 0.050 |
Why?
|
| Chicago | 2 | 2014 | 30 | 0.050 |
Why?
|
| Sleep | 1 | 2023 | 152 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 182 | 0.050 |
Why?
|
| Sexual Behavior | 1 | 2006 | 609 | 0.050 |
Why?
|
| Social Desirability | 3 | 2007 | 6 | 0.050 |
Why?
|
| Efferent Pathways | 1 | 2020 | 14 | 0.050 |
Why?
|
| Globus Pallidus | 1 | 2020 | 18 | 0.050 |
Why?
|
| Activities of Daily Living | 2 | 2010 | 105 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2020 | 84 | 0.040 |
Why?
|
| Reinforcement Schedule | 2 | 2009 | 14 | 0.040 |
Why?
|
| New York | 2 | 2009 | 71 | 0.040 |
Why?
|
| Education, Nonprofessional | 1 | 2019 | 1 | 0.040 |
Why?
|
| Anxiety Disorders | 3 | 2010 | 309 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 131 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 291 | 0.040 |
Why?
|
| Motor Skills | 2 | 2014 | 33 | 0.040 |
Why?
|
| Community Mental Health Services | 2 | 2010 | 32 | 0.040 |
Why?
|
| Counseling | 2 | 2008 | 116 | 0.040 |
Why?
|
| Aftercare | 1 | 2017 | 19 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2020 | 446 | 0.040 |
Why?
|
| Cross-Sectional Studies | 3 | 2012 | 2721 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 481 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2020 | 294 | 0.040 |
Why?
|
| Electromyography | 2 | 2010 | 55 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2010 | 225 | 0.040 |
Why?
|
| Autistic Disorder | 1 | 2015 | 37 | 0.030 |
Why?
|
| Language | 1 | 2016 | 157 | 0.030 |
Why?
|
| Athletic Performance | 1 | 2014 | 20 | 0.030 |
Why?
|
| Sex Distribution | 2 | 2006 | 215 | 0.030 |
Why?
|
| Vocational Guidance | 1 | 2013 | 2 | 0.030 |
Why?
|
| Behavioral Sciences | 1 | 2012 | 2 | 0.030 |
Why?
|
| Social Sciences | 1 | 2012 | 4 | 0.030 |
Why?
|
| Random Allocation | 2 | 2003 | 139 | 0.030 |
Why?
|
| Arousal | 2 | 2002 | 86 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2012 | 36 | 0.030 |
Why?
|
| Marital Status | 1 | 2011 | 40 | 0.020 |
Why?
|
| Women | 1 | 2010 | 27 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2010 | 12 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2009 | 7 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2016 | 517 | 0.020 |
Why?
|
| Alleles | 1 | 2011 | 321 | 0.020 |
Why?
|
| Nova Scotia | 1 | 2009 | 4 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 441 | 0.020 |
Why?
|
| Behavioral Symptoms | 1 | 2009 | 6 | 0.020 |
Why?
|
| Placebo Effect | 1 | 2009 | 13 | 0.020 |
Why?
|
| Placebos | 1 | 2009 | 37 | 0.020 |
Why?
|
| Americas | 1 | 2009 | 7 | 0.020 |
Why?
|
| Control Groups | 1 | 2008 | 2 | 0.020 |
Why?
|
| Paternal Behavior | 1 | 2008 | 3 | 0.020 |
Why?
|
| Suicide | 1 | 2010 | 118 | 0.020 |
Why?
|
| Bradycardia | 1 | 2008 | 7 | 0.020 |
Why?
|
| Sleep Stages | 1 | 2008 | 6 | 0.020 |
Why?
|
| Reinforcement, Social | 1 | 2008 | 3 | 0.020 |
Why?
|
| Long QT Syndrome | 1 | 2008 | 13 | 0.020 |
Why?
|
| Tachycardia | 1 | 2008 | 11 | 0.020 |
Why?
|
| Japan | 1 | 2009 | 305 | 0.020 |
Why?
|
| Weight Loss | 1 | 2009 | 131 | 0.020 |
Why?
|
| Single-Parent Family | 1 | 2007 | 4 | 0.020 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2007 | 3 | 0.020 |
Why?
|
| Camping | 1 | 2007 | 1 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2008 | 141 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 202 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2007 | 59 | 0.020 |
Why?
|
| Helping Behavior | 1 | 2007 | 6 | 0.020 |
Why?
|
| Social Conformity | 1 | 2007 | 13 | 0.020 |
Why?
|
| Dopamine | 1 | 2009 | 245 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 227 | 0.020 |
Why?
|
| Discrimination Learning | 1 | 2006 | 28 | 0.020 |
Why?
|
| Health Expenditures | 1 | 2007 | 32 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2006 | 23 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2007 | 208 | 0.020 |
Why?
|
| Pattern Recognition, Visual | 1 | 2006 | 29 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2007 | 195 | 0.020 |
Why?
|
| Maze Learning | 1 | 2006 | 105 | 0.020 |
Why?
|
| Pemoline | 1 | 2006 | 1 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2006 | 14 | 0.020 |
Why?
|
| Amphetamine | 1 | 2006 | 16 | 0.020 |
Why?
|
| Focus Groups | 1 | 2007 | 348 | 0.020 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2005 | 12 | 0.020 |
Why?
|
| Drug Costs | 1 | 2005 | 28 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2008 | 753 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2006 | 534 | 0.020 |
Why?
|
| Demography | 1 | 2005 | 175 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2004 | 75 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2004 | 66 | 0.010 |
Why?
|
| Psychophysiology | 1 | 2002 | 13 | 0.010 |
Why?
|
| Intelligence | 1 | 2002 | 12 | 0.010 |
Why?
|
| Family Health | 1 | 2003 | 56 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 2003 | 146 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2002 | 66 | 0.010 |
Why?
|
| Brain | 1 | 2009 | 1346 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 204 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2003 | 225 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 628 | 0.010 |
Why?
|